Insider Transactions last 24 months for Nektar Therapeutics  -  NSDQ: NKTR

 
Transactions
All Buy Sell Option Exercise
Filer's Name
Relationship/
Title
Trans.
Date
Trans. Type
Ownership Type
Security Type
Shares
Price
Trans.
Value
Total Shares Owned
Robin Howard WPresident & CEO02/18/2026DSDirectCOM423$73.00$30,879.0075,489
Zalevsky JonathanChief R&D Officer02/18/2026DSDirectCOM180$73.00$13,140.0021,174
Zalevsky JonathanChief R&D Officer01/20/2026DSDirectCOM3,867$35.67$137,935.8921,354
Robin Howard WPresident & CEO12/22/2025AADirectCOM21,667$0.00$0.0075,912
Zalevsky JonathanChief R&D Officer12/22/2025AADirectCOM6,250$0.00$0.0025,221
Robin Howard WPresident & CEO11/25/2025DSDirectCOM2,207$54.28$119,795.9654,245
Wilson Mark AndrewChief Legal Officer11/25/2025DSDirectCOM630$54.28$34,196.4021,585
Zalevsky JonathanChief R&D Officer11/25/2025DSDirectCOM1,157$54.28$62,801.9618,971
Robin Howard WPresident & CEO11/21/2025AADirectCOM7,110$0.00$0.0056,452
Wilson Mark AndrewChief Legal Officer11/21/2025AADirectCOM1,903$0.00$0.0022,215
Zalevsky JonathanChief R&D Officer11/21/2025AADirectCOM2,666$0.00$0.0020,128
Robin Howard WPresident & CEO09/09/2025DSDirectCOM1,210$48.18$58,297.8049,342
Robin Howard WPresident & CEO09/09/2025DSDirectCOM2,156$47.49$102,388.4450,552
Robin Howard WPresident & CEO09/09/2025DSDirectCOM1,200$46.41$55,692.0052,708
Robin Howard WPresident & CEO09/09/2025DSDirectCOM2,100$45.16$94,836.0053,908
Robin Howard WPresident & CEO09/05/2025DSDirectCOM1,136$39.89$45,315.0456,008
Robin Howard WPresident & CEO09/05/2025DSDirectCOM2,226$38.82$86,413.3257,144
Robin Howard WPresident & CEO09/05/2025DSDirectCOM3,304$37.87$125,122.4859,370
Robin Howard WPresident & CEO09/04/2025DSDirectCOM1,134$35.80$40,597.2062,674
Robin Howard WPresident & CEO09/04/2025DSDirectCOM613$34.40$21,087.2063,808
Robin Howard WPresident & CEO09/04/2025DSDirectCOM1,496$33.54$50,175.8464,421
Robin Howard WPresident & CEO09/04/2025DSDirectCOM1,923$32.37$62,247.5165,917
Zalevsky JonathanChief R&D Officer09/04/2025DSDirectCOM307$35.69$10,956.8317,462
Zalevsky JonathanChief R&D Officer09/04/2025DSDirectCOM189$34.41$6,503.4917,769
Zalevsky JonathanChief R&D Officer09/04/2025DSDirectCOM432$33.60$14,515.2017,958
1   2  3  Next Last  You are at page 1 of 3 pages
Transaction Type Key
First letter: A = Acquired, D = Disposed
Second letter:
A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust 		Export Table Data to Excel Send to Excel